Skip to content
Screener

Arrowhead Research ARWR Total Current Liabilities

Total Current Liabilities at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$315.64M-64.8%
ALN
Alnylam PharmaceuticalsALNY
$1.51B+16.3%
Assembly Biosciences logo
Assembly BiosciencesASMB
$35M-24.9%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$5.11M-73.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$351M+19.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$74.57M-47.3%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Deferred revenue108,5432,399
Credit facility40,00040,000
Other liabilities11,20510,811
Total current liabilities295,220195,487
Long-term liabilities:
Lease liabilities, net of current portion100,106104,112
Deferred revenue, net of current portion48,615
Liability related to the sale of future royalties383,829367,397

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's total current liabilities?
Arrowhead Research (ARWR) reported total current liabilities of $295.22M in Q1 2026.
How has Arrowhead Research's total current liabilities changed year-over-year?
Arrowhead Research's total current liabilities increased by 33.9% year-over-year, from $220.54M to $295.22M.
What is the long-term trend for Arrowhead Research's total current liabilities?
Over 4 years (2021 to 2025), Arrowhead Research's total current liabilities has grown at a 7.5% compound annual growth rate (CAGR), from $146.54M to $195.49M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Arrowhead Research's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude